Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Clin Endocrinol Metab. 2012 Jul;97(7):2223-30. doi: 10.1210/jc.2011-3355. Epub 2012 Apr 16.
ACTH-producing neuroendocrine tumor (NET) of the thymus is a rare cause of Cushing's syndrome (CS). The literature consists mainly of isolated case reports.
We studied 12 cases (eight males and four females) diagnosed between 1986 and 2010 with CS and thymic NET who underwent surgical resection.
We measured time from onset of CS to diagnosis of thymic NET, tumor size, histological grade, time to recurrence, and survival and performed a meta-analysis of other published cases of CS associated with thymic NET.
Eleven of 12 patients presented with classic features of CS at a median age of 21 yr (range, 7-51). Four were children. The 24-h urine free cortisol was greater than 16-fold of normal, and biochemical testing was consistent with ectopic ACTH production in all 11. Another patient presenting with pulmonary embolus had a thymic mass and was later diagnosed with CS. All patients underwent thymectomy, and nine of 10 tumors exhibited positive ACTH immunochemistry. Median tumor diameter was 5 cm (range, 1-11.5). Six patients recurred 20-28 months after surgery with metastases to mediastinal lymph nodes (n = 5), bone (n = 5), liver (n = 1), parotid gland (n = 1), and breast (n = 1). Four of five patients treated with radiation therapy also received chemotherapy. All recurrent patients received ketoconazole; four later underwent bilateral adrenalectomy. Six recurrent patients died 22-90 months (median, 57) after thymectomy. At last review, six patients were alive 14-90 months (median, 49) after thymectomy. These data are similar to those from the meta-analysis.
Thymic ACTH-producing NET is an aggressive disease that should be considered in CS with ectopic ACTH secretion, particularly in younger patients.
促肾上腺皮质激素(ACTH)产生的胸腺神经内分泌肿瘤(NET)是库欣综合征(CS)的罕见病因。文献主要由孤立的病例报告组成。
我们研究了 1986 年至 2010 年间经手术切除诊断为 CS 和胸腺 NET 的 12 例病例(8 名男性和 4 名女性)。
我们测量了 CS 至胸腺 NET 诊断的时间、肿瘤大小、组织学分级、复发时间、生存时间,并对其他与胸腺 NET 相关的 CS 病例进行了荟萃分析。
12 例患者中有 11 例表现为 CS 的典型特征,中位年龄为 21 岁(范围,7-51 岁)。4 例为儿童。24 小时尿游离皮质醇高于正常的 16 倍,11 例患者的生化检查均符合异位 ACTH 产生。另一位因肺栓塞就诊的患者有胸腺肿块,后被诊断为 CS。所有患者均接受了胸腺切除术,其中 10 例肿瘤中有 9 例显示 ACTH 免疫化学阳性。肿瘤直径中位数为 5cm(范围,1-11.5cm)。6 例患者在手术后 20-28 个月复发,转移至纵隔淋巴结(n=5)、骨(n=5)、肝(n=1)、腮腺(n=1)和乳腺(n=1)。5 例接受放疗的患者中有 4 例还接受了化疗。所有复发患者均接受酮康唑治疗,4 例患者随后行双侧肾上腺切除术。6 例复发患者在胸腺切除术 22-90 个月(中位,57 个月)后死亡。末次随访时,6 例患者在胸腺切除术 14-90 个月(中位,49 个月)后存活。这些数据与荟萃分析相似。
胸腺 ACTH 产生的 NET 是一种侵袭性疾病,在异位 ACTH 分泌的 CS 中应考虑到这一点,尤其是在年轻患者中。